1
Gary L Rayburn, Rob G Riffle, Frederick J Walburn, Benjamin G Williams: Endoscopic device and method for reinforcing surgical staples. Gore Enterprise Holdings, David J Johns, September 22, 1998: US05810855 (800 worldwide citation)

A surgical staple line reinforcement device for use with a variety of surgical staplers having a pivoted connection between stapler arms or jaws, such as endoscopic stapler devices. The device comprises a pair of tubes of bio-implantable material connected together at a hinge. The device can be quic ...


2
Gary L Rayburn, Rob G Riffle, Frederick J Walburn, Benjamin G Williams: Device and method for reinforcing surgical staples. W L Gore & Associates, David J Johns, December 30, 1997: US05702409 (595 worldwide citation)

A surgical staple line reinforcement device for use with a variety of surgical staplers to protect against tissue damage from surgical staples. The device comprises a tube of bio-implantable material that can be quickly and readily applied by a surgical team to provide tissue reinforcement. The devi ...


3
Stanley L Mills, Jacqueline L Mills, Robert D Maurer, Gary L Rayburn, Marvin A Cuchens: Transdermal venous access locking solutions. Organic Medical Ventures L L C, Hall Estill Law Firm, July 7, 2015: US09072296 (8 worldwide citation)

Microbial growth inhibiting solutions and methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices are disclosed. In alternative embodiments, the microbial growth inhibiting solutions include combinations of a chelating agent with a C4-C9 carboxylate ant ...


4
Stanley L Mills, Jacqueline L Mills, Robert D Maurer, Gary L Rayburn, Marvin A Cuchens: Transdermal venous access locking solutions. Hall Estill Law Firm, September 6, 2016: US09433209

Microbial growth inhibiting solutions and methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices are disclosed. In alternative embodiments, the microbial growth inhibiting solutions include combinations of a chelating agent with a C4-C9, C10 or C12 car ...


5
Stanley L Mills, Jacqueline L Mills, Robert D Maurer, Gary L Rayburn, Marvin A Cuchens: Syringe treated with transdermal venous access locking solutions and method of treating the syringe. Hall Estill Law Firm, August 30, 2016: US09427498

Microbial growth inhibiting solutions and methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices are disclosed. In alternative embodiments, the microbial growth inhibiting solutions include combinations of a chelating agent with a C4-C12 carboxylate an ...


6
Stanley L Mills, Jacqueline L Mills, Robert D Maurer, Gary L Rayburn, Marvin A Cuchens: Transdermal venous access locking solutions. Hall Estill Law Firm, July 5, 2016: US09380780

Microbial growth inhibiting solutions and methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices are disclosed. In alternative embodiments, the microbial growth inhibiting solutions include combinations of a chelating agent with a C4-C9 carboxylate ant ...


7
Stanley L Mills, Jacqueline L Mills, Robert D Maurer, Gary L Rayburn, Marvin A Cuchens: Transdermal venous access locking solution. Organic Medical Ventures, Richard G Gervase, Mintz Levin Cohn Ferris Glovsky and Popeo PC, September 30, 2010: US20100249747-A1

Compositions and methods of employing compositions in flushing and coating medical devices are disclosed. The compositions include combinations of a chelating agent, anticoagulant, or antithrombotic agent, with a C4-C9 carboxylate antimicrobial agent, such as octanoic acid. Methods of using these co ...


8
Stanley L Mills, Jacqueline L Mills, Robert D Maurer, Gary L Rayburn, Marvin A Cuchens: Transdermal venous access locking solutions. Organic Medical Ventures, December 22, 2011: US20110311602-A1

Microbial growth inhibiting solutions and methods of employing the microbial growth inhibiting solutions in flushing and coating medical devices are disclosed. In alternative embodiments, the microbial growth inhibiting solutions include combinations of a chelating agent with a C4-C9 carboxylate ant ...